Document Detail


Availability of cysteine and of L-2-oxo-thiazolidine-4-carboxylic acid as a source of cysteine in intravenous nutrition.
MedLine Citation:
PMID:  2112627     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cysteine is usually not included in amino acid solutions for intravenous nutrition for two reasons: it is not considered to be an essential amino acid, and it causes stability problems in solutions. The cysteine content of a solution decreases markedly in the presence of oxygen and/or glucose due to formation of various derivatives, such as cystine and D-glucocysteine. It is not clear if the formed derivatives are available for metabolic processes. A cysteine analogue, L-2-oxothiazolidine-4-carboxylic acid (OTCA), is stable in solutions and can be metabolized in the body-yielding cysteine. The metabolic availability of cysteine and OTCA from an all-in-one total parenteral nutrition (TPN) mixture was evaluated in the rat and compared to a regimen with cysteine infused from a separate container. A cysteine-free TPN mixture served as a control. All mixtures contained a suboptimal amount of methionine, which can normally be metabolized to cysteine, to enhance the nutritional effect of cysteine or OTCA supplement. The cysteine content in the admixture decreased approximately 40% during 30 hr after mixing. Nevertheless the utilization of this admixture was identical to the regimen supplying cysteine separately. The admixture containing OTCA showed similar results as the two cysteine regimens. All three regimens promoted growth significantly better than the cysteine-free-mixture. The results suggest that 1) cysteine is available for metabolic processes from its derivatives formed in an all-in-one TPN mixture, and 2) OTCA acts as a precursor of cysteine to the rat when supplied as a part of TPN.
Authors:
L Bjelton; G B Fransson
Related Documents :
21191617 - Erratum to: solvent-free geranyl oleate production by enzymatic esterification.
12141547 - Aquatic phototransformation study of the antifouling agent sea-nine 211: identification...
22553437 - Comparison of norfloxacin versus nalidixic acid in therapy of acute urinary tract infec...
9648027 - Complexation of basic fibroblast growth factor with gelatin.
7234717 - Hydrogenated oils and fats: the presence of chemically-modified fatty acids in human ad...
6224747 - Effect of 13-cis-retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  JPEN. Journal of parenteral and enteral nutrition     Volume:  14     ISSN:  0148-6071     ISO Abbreviation:  JPEN J Parenter Enteral Nutr     Publication Date:    1990 Mar-Apr
Date Detail:
Created Date:  1990-07-13     Completed Date:  1990-07-13     Revised Date:  2007-02-21    
Medline Journal Info:
Nlm Unique ID:  7804134     Medline TA:  JPEN J Parenter Enteral Nutr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  177-82     Citation Subset:  IM    
Affiliation:
Vitrum Institute for Human Nutrition, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Availability
Cysteine / administration & dosage,  pharmacokinetics*
Food, Formulated
Male
Parenteral Nutrition, Total*
Pyrrolidonecarboxylic Acid
Rats
Rats, Inbred Strains
Thiazoles / administration & dosage,  pharmacokinetics*
Thiazolidines
Weight Gain
Chemical
Reg. No./Substance:
0/Thiazoles; 0/Thiazolidines; 19750-45-9/2-oxothiazolidine-4-carboxylic acid; 52-90-4/Cysteine; 98-79-3/Pyrrolidonecarboxylic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Home enteral nutrition system: one patient, one daily ration of an "all-in-one" sterile and modular ...
Next Document:  Serum vitamin A and E concentrations in pediatric total parenteral nutrition patients.